Clinical Trial Update: Anticoagulation in Patients With Venous Thromboembolism and Cancer

View source ↗

Summary

Pfizer-sponsored clinical trial evaluating anticoagulation in cancer patients with venous thromboembolism is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Snippet

Sponsor: Pfizer | Conditions: Neoplasms, Embolism | Status: ACTIVE_NOT_RECRUITING